Funds trio key shareholders in Open Orphan merger firm

16th June, 2019
Open Orphan boss Cathal Friel

A trio of London funds have emerged as major shareholders in Venn Life Sciences as part of its merger with Open Orphan.

The company announced last week that it has raised £4.5 million (€5 million) from investors to fund the reverse takeover of Dublin-based Open Orphan.

According to regulatory filings on Friday, Miton Asset Management and Crux Asset Management will each own 3.5 per cent of Open Orphan after the fundraising is complete. Livingbridge, a...

Subscribe from just €1 for the first month!


What's Included

With any subscription you will have access to

  • 971569B3-2C5E-4C45-B798-CEADE16987A8

    Unlimited multi-device access to our iPad, iPhone and Android Apps

  • 099C8662-C57C-42F2-9426-F2F90DF17C8F

    Unlimited access to our eReader library

  • 198AE43B-B9CF-4892-8769-D63C2104BA08

    Exclusive daily insight and opinion seven days a week

  • D8F37B78-25E4-4E4A-A376-4F5789B1564A

    Create alerts to never miss a subject that matters to you

  • B15F2521-37CD-4E02-B898-730A20D39F7F

    Get access to exclusive offers for subscribers on gifts and experiences

  • A564FE02-1AB8-4579-AF9D-BA32A2E5ACA7

    Get content from Business Post, Business Post Magazines, Connected, Tatler and Food & Wine

Share this post

Related Stories

The twelve deals of the year

Alphabet soup: 2021 in review

EY reports €393m revenues in Republic of Ireland for 2021 financial year